Table 6.
Distribution of cervical lymph-adenopathy according to their mode of presentation (N = 423)
| Mode of presentation | Cancer lymph node | Tubercular lymphadenitis | Non-specific lymphadenitis/reactive hyperplasia | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Present | Absent | X2, df, P | Present | Absent | X2, df, P | Present | Absent | X2, df, P | |
| Early (<2 weeks) | 18 (18.2) | 81 | 7.01, 2, 0.03002604 | 48 (48.5) | 51 | 6.01, 2, 0.04962676 | 33 (33.3) | 66 | 7.35, 2, 0.02529235 |
| Intermediate (2–6 weeks) | 39 (29.5) | 93 | 69 (52.3) | 63 | 24 (18.2) | 108 | |||
| Late (>6 weeks) | 63 (32.8) | 129 | 75 (39.1) | 117 | 54 (28.1) | 138 | |||